NCT03557398View on ClinicalTrials.gov

Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

May 29, 2018

Study Completion Date

May 29, 2018

Conditions
Vulvovaginal Atrophy
Interventions
DEVICE

Hydeal-D vaginal pessaries

One vaginal application of Hydeal-D vaginal pessaries every 3 days to a total of 12 consecutive weeks.

Trial Locations (2)

83107

Gynkomed s.r.o., Bratislava

920 01

ULMUS, s r.o., Hlohovec

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY